Abstract
Galectin-3-binding protein (G3BP) is highly expressed in various types of cancer and is thought to be involved in cancer malignancy; however, the role of G3BP in breast cancer cells is not fully understood. In this study, we investigated the role of NF-κB in the adhesion of breast cancer cells to a substrate by using (-)-DHMEQ, a specific inhibitor of NF-κB. (-)-DHMEQ inhibited both TNF-α-induced G3BP expression and cell adhesion in human breast cancer cell lines. We also found that knockdown of G3BP suppressed the adhesion, while its overexpression increased the adhesion. These data reveal that (-)-DHMEQ suppresses breast cancer cell adhesion by inhibiting NF-κB-regulated G3BP expression.
Original language | English |
---|---|
Pages (from-to) | 2080-2084 |
Number of pages | 5 |
Journal | Oncology reports |
Volume | 27 |
Issue number | 6 |
DOIs | |
Publication status | Published - 2012 Jun |
Keywords
- Adhesion
- Breast cancer
- Galectin-3-binding protein
- NF-κB
ASJC Scopus subject areas
- Oncology
- Cancer Research